PDCD1 and nasopharyngeal carcinoma: In this systematic review and network meta-analysis, we comprehensively evaluated the comparative efficacy and safety of various first-line treatment options, including all available PD-1 inhibitors and their combination strategies, for patients with RM-NPC.